Contesting the dogma of an age-related heat shock response impairment: Implications for cardiac-specific age-related disorders

Human Molecular Genetics

Volumn 23, Issue 14, 2014, Pages 3641-3656

  Carnemolla, Alisia ^a   Labbadia, John P ^a   Lazell, Hayley ^a   Neueder, Andreas ^a   Moussaoui, Saliha ^b,c   Bates, Gillian P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Rhenovia Pharma   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90 INHIBITOR; HEAT SHOCK TRANSCRIPTION FACTOR 1; SIRTUIN 1; 2-AMINO-7-(4-FLUORO-2-(6-METHOXYPYRIDIN-2-YL)PHENYL)-4-METHYL-7,8-DIHYDROPYRIDO(4,3-D)PYRIMIDIN-5(6H)-ONE; DNA BINDING PROTEIN; HSF1 PROTEIN, MOUSE; PYRIDONE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

AGE; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORPUS STRIATUM; DNA BINDING; DOWN REGULATION; FEMALE; HEAT SHOCK RESPONSE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; UNFOLDED PROTEIN RESPONSE; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN; C57BL MOUSE; CBA MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART MUSCLE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MYOCARDIUM; PROTEIN FOLDING; PYRIDONES; PYRIMIDINES; TRANSCRIPTION FACTORS;

EID: 84902979865     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu073     Document Type: Article

References (50)

1. Kenyon, C.J. (2010) The genetics of ageing. Nature, 464, 504-512.
2. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell, 153, 1194-1217.
3. Akerfelt, M., Morimoto, R.I. and Sistonen, L. (2010) Heat shock factors: integrators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol., 11, 545-555.
4. Ron, D. and Walter, P. (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol., 8, 519-529.
5. Haynes, C.M. and Ron, D. (2010) The mitochondrial UPR - protecting organelle protein homeostasis. J. Cell Sci., 123, 3849-3855.
6. Wang, C.H., Wu, S.B., Wu, Y.T. and Wei, Y.H. (2013) Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp. Biol. Med., 238, 450-460.
7. Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science, 319, 916-919.
8. Ben-Zvi, A., Miller, E.A. and Morimoto, R.I. (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc. Natl Acad. Sci. USA, 106, 14914-14919.
9. Tonoki, A., Kuranaga, E., Tomioka, T., Hamazaki, J., Murata, S., Tanaka, K. and Miura, M. (2009) Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol. Cell Biol., 29, 1095-1106.
10. Taylor, R.C. and Dillin, A. (2013) XBP-1 is a cell-nonautonomous regulator of stress resistance and longevity. Cell, 153, 1435-1447.
11. Locke, M. and Tanguay, R.M. (1996) Diminished heat shock response in the aged myocardium. Cell Stress Chaperones, 1, 251-260.
12. Locke, M. (2000) Heat shock transcription factor activation and hsp72 accumulation in aged skeletal muscle. Cell Stress Chaperones, 5, 45-51.
13. Gagliano, N., Grizzi, F. and Annoni, G. (2007) Mechanisms of aging and liver functions. Dig. Dis., 25, 118-123.
14. Kayani, A.C., Close, G.L., Broome, C.S., Jackson, M.J. and McArdle, A. (2008) Enhanced recovery from contraction-induced damage in skeletal muscles of old mice following treatment with the heat shock protein inducer 17-(allylamino)-17-demethoxygeldanamycin. Rejuvenation Res., 11, 1021-1030.
15. Hall, D.M., Xu, L., Drake, V.J., Oberley, L.W., Oberley, T.D., Moseley, P.L. and Kregel, K.C. (2000) Aging reduces adaptive capacity and stress protein expression in the liver after heat stress. J. Appl. Physiol., 89, 749-759.
16. Kregel, K.C. and Moseley, P.L. (1996) Differential effects of exercise and heat stress on liver HSP70 accumulation with aging. J. Appl. Physiol., 80, 547-551.
17. Labbadia, J., Cunliffe, H., Weiss, A., Katsyuba, E., Sathasivam, K., Seredenina, T., Woodman, B., Moussaoui, S., Frentzel, S., Luthi-Carter, R. et al. (2011) Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J. Clin. Invest., 121, 3306-3319.
18. Sarge, K.D., Murphy, S.P. and Morimoto, R.I. (1993) Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol. Cell Biol., 13, 1392-1407.
19. Westerheide, S.D., Anckar, J., Stevens, S.M. Jr., Sistonen, L. and Morimoto, R.I. (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science, 323, 1063-1066.
20. Egorin, M.J., Zuhowski, E.G., Rosen, D.M., Sentz, D.L., Covey, J.M. and Eiseman, J.L. (2001) Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17- demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Cancer Chemother. Pharmacol., 47, 291-302.
21. Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M. and Sobue, G. (2005) 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat. Med., 11, 1088-1095.
22. Kim, H.R., Kang, H.S. and Kim, H.D. (1999) Geldanamycin induces heat shock protein expression through activation of HSF1 in K562 erythroleukemic cells. IUBMB Life, 48, 429-433.
23. Menezes, D.L., Taverna, P., Jensen, M.R., Abrams, T., Stuart, D., Yu, G.K., Duhl, D., Machajewski, T., Sellers, W.R., Pryer, N.K. et al. (2012) The novel oral Hsp90 inhibitor NVP-HSP990 exhibits potent and broad-spectrum antitumor activities in vitro and in vivo. Mol. Cancer Ther., 11, 730-739.
24. Khong, T. and Spencer, A. (2011) Targeting HSP 90 induces apoptosis and inhibits critical survival and proliferation pathways in multiple myeloma. Mol. Cancer Ther., 10, 1909-1917.
25. Xiao, X., Zuo, X., Davis, A.A., McMillan, D.R., Curry, B.B., Richardson, J.A. and Benjamin, I.J. (1999) HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J., 18, 5943-5952.
26. Nadeau, K., Das, A. and Walsh, C.T. (1993) Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J. Biol. Chem., 268, 1479-1487.
27. Zou, J., Guo, Y., Guettouche, T., Smith, D.F. and Voellmy, R. (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell, 94, 471-480.
28. Shi, Y., Mosser, D.D. and Morimoto, R.I. (1998) Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev., 12, 654-666.
29. Gutsmann-Conrad, A., Pahlavani, M.A., Heydari, A.R. and Richardson, A. (1999) Expression of heat shock protein 70 decreases with age in hepatocytes and splenocytes from female rats. Mech. Ageing Dev., 107, 255-270.
30. Heydari, A.R., You, S., Takahashi, R., Gutsmann-Conrad, A., Sarge, K.D. and Richardson, A. (2000) Age-related alterations in the activation of heat shock transcription factor 1 in rat hepatocytes. Exp. Cell Res., 256, 83-93.
31. DiDomenico, B.J., Bugaisky, G.E. and Lindquist, S. (1982) The heat shock response is self-regulated at both the transcriptional and posttranscriptional levels. Cell, 31, 593-603.
32. Hay, D.G., Sathasivam, K., Tobaben, S., Stahl, B., Marber, M., Mestril, R., Mahal, A., Smith, D.L., Woodman, B. and Bates, G.P. (2004) Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach. Hum. Mol. Genet., 13, 1389-1405.
33. Zourlidou, A., Gidalevitz, T., Kristiansen, M., Landles, C., Woodman, B., Wells, D.J., Latchman, D.S., de Belleroche, J., Tabrizi, S.J., Morimoto, R.I. et al. (2007) Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation. Hum. Mol. Genet., 16, 1078-1090.
34. Rahman, M.M., Sykiotis, G.P., Nishimura, M., Bodmer, R. and Bohmann, D. (2013) Declining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes. Aging Cell, 12, 554-562.
35. Fontana, L., Vinciguerra, M. and Longo, V.D. (2012) Growth factors, nutrient signaling, and cardiovascular aging. Circ. Res., 110, 1139-1150.
36. David, R. and Franz, W.M. (2012) From pluripotency to distinct cardiomyocyte subtypes. Physiology, 27, 119-129.
37. Willis, M.S. and Patterson, C. (2013) Proteotoxicity and cardiac dysfunction--Alzheimer's disease of the heart? N. Engl. J. Med., 368, 455-464.
38. Henderson, B. and Pockley, A.G. (2012) Proteotoxic stress and circulating cell stress proteins in the cardiovascular diseases. Cell Stress Chaperones, 17, 303-311.
39. Holland, A., Dowling, P., Zweyer, M., Swandulla, D., Henry, M., Clynes, M. and Ohlendieck, K. (2013) Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin. Proteomics, 13, 2312-2323.
40. Sanbe, A., Osinska, H., Saffitz, J.E., Glabe, C.G., Kayed, R., Maloyan, A. and Robbins, J. (2004) Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc. Natl Acad. Sci. USA, 101, 10132-10136.
41. Glabe, C.G. (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging, 27, 570-575.
42. Buxbaum, J.N. (2004) The systemic amyloidoses. Curr. Opin. Rheumatol., 16, 67-75.
43. Guarente, L. (2011) Sirtuins, aging, and metabolism. Cold Spring Harb. Symp. Quant. Biol., 76, 81-90.
44. Donmez, G. and Guarente, L. (2010) Aging and disease: connections to sirtuins. Aging Cell, 9, 285-290.
45. Cornwell, G.G. III, Murdoch, W.L., Kyle, R.A., Westermark, P. and Pitkanen, P. (1983) Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am. J. Med., 75, 618-623.
46. Tanskanen, M., Peuralinna, T., Polvikoski, T., Notkola, I.L., Sulkava, R., Hardy, J., Singleton, A., Kiuru-Enari, S., Paetau, A., Tienari, P.J. et al. (2008) Senile systemic amyloidosis affects25%of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann. Med., 40, 232-239.
47. Dungu, J.N., Anderson, L.J., Whelan, C.J. and Hawkins, P.N. (2012) Cardiac transthyretin amyloidosis. Heart, 98, 1546-1554.
48. Hockly, E., Woodman, B., Mahal, A., Lewis, C.M. and Bates, G. (2003) Standardization and statistical approaches to therapeutic trials in the R6/2 mouse. Brain Res. Bull., 61, 469-479.
49. Benn, C.L., Fox, H. and Bates, G.P. (2008) Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington's disease. Mol. Neurodegener., 3, 17.
50. Landles, C., Sathasivam, K., Weiss, A., Woodman, B., Moffitt, H., Finkbeiner, S., Sun, B., Gafni, J., Ellerby, L.M., Trottier, Y. et al. (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J. Biol. Chem., 285, 8808-8823.